MannKind Corporation (MNKD) News: Substantial Take Off, Zacks Score and More
An enormous call trade tops today's option activity in biopharmaceutical company MannKind Corporation (NASDAQ:MNKD) as takeover speculation rises.
Mannkind Corp (MNKD)
Market is closed
News
- First
- << Previous
- 91 - 100
- Next >>
MannKind Corporation (MNKD): Why Have Shares Moved?
MannKind Corporation (NASDAQ:MNKD) took one giant leap over the past few days. Shares have soared more than 30% since last week, after the company reported results for the first quarter.
Vertex Pharmaceuticals Incorporated (VRTX): What You Need To Know
What's the source of your investment strategy? Many look to great investors like Warren Buffett for guidance on how to invest.
MannKind Corporation (MNKD): Should You Buy?
Perennial underdog MannKind Corporation (NASDAQ:MNKD) could be on its countdown to liftoff. The company announced its first-quarter results after the market closed on Thursday.
Vertex Pharmaceuticals Incorporated (VRTX), MannKind Corporation (MNKD): Want to Invest in Biotech? Think Like a Venture Capitalist
They're demanding. They take risks -- but only calculated ones. And they ask lots of penetrating questions to understand as much as possible before putting a dime on the line.
Is MannKind Corporation (MNKD) Going to Burn These Hedge Funds?
MannKind Corporation (NASDAQ:MNKD) was in 8 hedge funds' portfolio at the end of December. MNKD shareholders have witnessed an increase in hedge fund interest of late.
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE) and Big Pharma Led the Dow Jones Industrial Average (.DJI) to New Highs Today
Investors have been as clear as they can be about what they see as their ideal situation.
Puma Biotechnology Inc (PBYI), Achillion Pharmaceuticals, Inc. (ACHN): Here is What Hedge Funds Think About NPS Pharmaceuticals, Inc. (NPSP)
According to most investors, hedge funds are perceived as worthless, old financial tools of years past.
Sarepta Therapeutics Inc (SRPT), Keryx Biopharmaceuticals (KERX), MannKind Corporation (MNKD): Three Speculative Biotech Companies Primed to Pop
They don't have any products on the market. They have little or no revenue. Earnings? Nada. Many people are betting that they will fail.
PDL BioPharma Inc. (NASDAQ:PDLI): Insiders Are Dumping, Should You? - Santarus, Inc. (NASDAQ:SNTS), VIVUS, Inc. (NASDAQ:VVUS)
In the 21st century investor’s toolkit, there are a multitude of indicators investors can use to track publicly traded companies. Two of the best are hedge fund and insider trading movement.
- First
- << Previous
- 91 - 100
- Next >>
Billionaire Hedge Funds
